Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice.

Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun. 2003 Feb; 20(1):15-25.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.